These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38699449)

  • 1. Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.
    Wang JR; Mendez Araque SJ; Micciche G; McMillan A; Coughlin E; Mattiola R; English D; Kaliebe K
    Front Psychiatry; 2024; 15():1301960. PubMed ID: 38699449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.
    Mayer CE; LeBaron VT; Acquaviva KD
    J Psychoactive Drugs; 2022; 54(1):81-92. PubMed ID: 34266372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.
    Meir P; Taylor L; Soares JC; Meyer TD
    J Affect Disord; 2023 Feb; 323():748-754. PubMed ID: 36535547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.
    Plourde L; Chang SL; Farzin H; Gagnon P; Hébert J; Foxman R; Deschamps P; Provost F; Masse-Grenier M; Stephan JF; Cheung K; Joly Y; Fallu JS; Dorval M;
    Palliat Med; 2024 Feb; 38(2):272-278. PubMed ID: 38253521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.
    Wang K; Sun Y; Nava B; Sampiere L; Jacobs RJ
    Cureus; 2023 Apr; 15(4):e37450. PubMed ID: 37181969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.
    Bhuiya NMA; Jacobs RJ; Wang K; Sun Y; Nava B; Sampiere L; Yerubandi A; Caballero J
    Cureus; 2023 Sep; 15(9):e45169. PubMed ID: 37842360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psilocybin in Palliative Care: An Update.
    Whinkin E; Opalka M; Watters C; Jaffe A; Aggarwal S
    Curr Geriatr Rep; 2023; 12(2):50-59. PubMed ID: 37305379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older adults in psychedelic-assisted therapy trials: A systematic review.
    Bouchet L; Sager Z; Yrondi A; Nigam KB; Anderson BT; Ross S; Petridis PD; Beaussant Y
    J Psychopharmacol; 2024 Jan; 38(1):33-48. PubMed ID: 38240068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
    Agin-Liebes GI; Malone T; Yalch MM; Mennenga SE; Ponté KL; Guss J; Bossis AP; Grigsby J; Fischer S; Ross S
    J Psychopharmacol; 2020 Feb; 34(2):155-166. PubMed ID: 31916890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
    Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
    J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.
    Gray JC; Murphy M; Carter SE; Johnson MW; Wolfgang AS; Roy MJ; Maples-Keller JL
    Mil Med; 2023 Nov; 188(11-12):e3356-e3362. PubMed ID: 36564939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.
    Downey AE; Boyd M; Chaphekar AV; Woolley J; Raymond-Flesch M
    Int J Eat Disord; 2023 Nov; 56(11):2142-2148. PubMed ID: 37551650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.
    Rosa WE; Sager Z; Miller M; Bernstein I; Doerner Rinaldi A; Addicott K; Ljuslin M; Adrian C; Back AL; Beachy J; Bossis AP; Breitbart WS; Cosimano MP; Fischer SM; Guss J; Knighton E; Phelps J; Richards BD; Richards WA; Tulsky JA; Williams MT; Beaussant Y
    J Palliat Med; 2022 Aug; 25(8):1273-1281. PubMed ID: 35285721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.
    Lehto RH; Miller M; Sender J
    J Holist Nurs; 2022 Sep; 40(3):265-280. PubMed ID: 34482761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption as an opportunity or threat: A qualitative analysis of factors influencing the attitudes of experts in serious illness care toward psychedelic-assisted therapies.
    Sholevar R; Peteet J; Sanders J; Beaussant Y
    Palliat Support Care; 2023 Oct; ():1-6. PubMed ID: 37818641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.
    Altman BR; Earleywine M; De Leo J
    J Psychoactive Drugs; 2022; 54(5):462-470. PubMed ID: 34979875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.
    Husain MI; Blumberger DM; Castle DJ; Ledwos N; Fellows E; Jones BDM; Ortiz A; Kloiber S; Wang W; Rosenblat JD; Mulsant BH
    BJPsych Open; 2023 Jul; 9(4):e134. PubMed ID: 37489299
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.